XRF Scientific Limited (ASX: XRF) - ETF Exposure

- Current share price for XRF : $2.120

XRF Scientific Limited (XRF) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a Company engaged in manufacturing and marketing metal products, specialised chemicals and instruments for the scientific, analytical and mining industries.

XRF General Information ⁺

ASX Code	XRF
Website	http://www.xrfscientific.com
Industry/Sector	Industrial Machinery
Market Cap ($M)	306
XRF Share Price	$2.120
Day High	$2.160
Day Low	$2.110
Last Close	$2.120
XRF Share Price Movement	- ( No change )

Prices as at 16:40, 30 Oct 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to XRF

XRF Scientific Limited (XRF) is held across 1 ETF spanning strategies that include industrial machinery exposure . Its weighting in those funds means performance can have an outsized influence - when XRF moves, funds like DACE that hold it can move with it.

For more concentrated exposure, ETFs such as DACE (Dimensional Australian Core Equity (Managed Fund)) allocate about 0% to XRF , while the average exposure across all 1 ETF that hold it is around 0% .

Top ETF holdings

Dimensional Australian Core Equity (Managed Fund) (DACE) ~ 0%

Last updated: ETF data and holdings as at 1 November 2026

Own XRF directly or through an ETF?

How does holding XRF Scientific Limited (XRF) shares directly compare to ETFs that include it?

	XRF Direct	DACE ASX
Holdings	1 company	510 holdings
XRF Weight	100%	0%
Diversification	Single Stock	Broad
Annual Cost	Brokerage only	0.28% p.a.
Approx. Yield	2.6%	3.17%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not XRF's direct yield. Annual cost uses each ETF's MER.

XRF Exposure on $10,000 investment

How a $10,000 investment in XRF Scientific Limited (XRF) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
XRF Scientific Limited (XRF)	Direct share	$2.120	13.98%	+$1,398	$11,398
Dimensional Australian Core Equity (Managed Fund) (DACE)	Equity - Australia Strategy	$18.600	1.47%	+$147	$10,147

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

XRF Scientific Limited (XRF) ETFs

1 ETF hold XRF Scientific Limited (XRF).

ETF	XRF Weight	MER	Yield
Dimensional Australian Core Equity (Managed Fund) (DACE)	0%	0.28%	3.17%

XRF Scientific Limited (XRF) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
HFResult	4.5¢	100%	10 Sep 2026	25 Sep 2026	-	-	-
HFResult	4.5¢	100%	11 Sep 2025	26 Sep 2025	-	-	-
HFResult	3.9¢	100%	12 Sep 2024	27 Sep 2024	-	-	-

See all dividends from XRF Scientific Limited (XRF) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

XRF Scientific Limited (XRF) price-sensitive announcements

XRF - September 2026 Quarterly Trading Report

XRF Scientific Limited’s September 2026 Quarterly Trading Report states that the company d

XRF Scientific Limited (XRF)
13 Oct 2026 | 9:53 AM

XRF - August 2026 Investor Presentation

The August 2026 Investor Presentation for XRF Scientific Limited highlighted several key d

XRF Scientific Limited (XRF)
18 Aug 2026 | 9:13 AM

XRF - XRF announces record full-year result

XRF Scientific Limited announced a record full-year result for the financial year ending J

XRF Scientific Limited (XRF)
18 Aug 2026 | 9:10 AM

XRF - Preliminary Final Report

The preliminary final report for XRF Scientific Limited for the financial year ending 30 J

XRF Scientific Limited (XRF)
18 Aug 2026 | 9:06 AM

XRF Scientific Limited (XRF) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
XRF Scientific Limited (XRF) ORDINARY FULLY PAID	Industrials	$307	Change of Director's Interest Notice - F. Grimwade	21 Oct 2026 3:40PM	$1.850	$2.120	risen by 14.59%
XRF Scientific Limited (XRF) ORDINARY FULLY PAID	Industrials	$307	Results of Meeting	19 Oct 2026 6:21PM	$1.875	$2.120	risen by 13.07%
XRF Scientific Limited (XRF) ORDINARY FULLY PAID	Industrials	$307	2026 AGM Presentation	19 Oct 2026 8:07AM	$1.870	$2.120	risen by 13.37%
XRF Scientific Limited (XRF) ORDINARY FULLY PAID	Industrials	$307	September 2026 Quarterly Trading Report	13 Oct 2026 9:53AM	$1.655	$2.120	risen by 28.10%
XRF Scientific Limited (XRF) ORDINARY FULLY PAID	Industrials	$307	Change of Director's Interest Notice - D. Kiggins	28 Sep 2026 1:09PM	$1.760	$2.120	risen by 20.45%
XRF Scientific Limited (XRF) ORDINARY FULLY PAID	Industrials	$307	Change of Director's Interest Notice - F. Grimwade	28 Sep 2026 1:08PM	$1.760	$2.120	risen by 20.45%

XRF Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	PER	DPS	Yield (%)	Franking (%)
2028F	C2	$10.40	15.60%	20.40	6.30	3.00%	0.0%
2027F	C2	$9.00	15.70%	23.60	5.40	2.60%	0.0%
2026A	$11.18	$7.80	5.00%	25.30	4.50	2.30%	100.0%

XRF Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2026 A	2027 F	2028 F	2026 A	2027 F	2028 F	2026 A	2027 F	2028 F
Silex Systems Limited (SLX)	$970M	-0.2093	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
XRF Scientific Limited (XRF)	$307M	0.0499	0.1568	0.1556	27.2494	23.5556	20.3846	2.12%	2.55%	2.97%

XRF Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.44	25.90	4.57	1.66
Market	0.30	13.20	1.03	0.74
Sector	0.39	16.30	1.75	0.95

XRF Directors

Name	Position	Start Date
Mr Vance Stazzonelli	Company Secretary, Chief Executive Officer, Managing Director	22 Feb 2018
Mr David William Kiggins	Non-Executive Director	1 May 2012
Sir David Maxwell Brown	Non-Executive Director	9 Feb 2004
Mr Frederick Sheppard Grimwade	Non-Executive Director, Non-Executive Chairman	1 May 2012

XRF Scientific Limited (XRF) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
21 Oct 2026	GRIMWADE, Frederick	Buy	Indirect Shares	6,900	$1.888	$13,024.000
25 Sep 2026	KIGGINS, David	Issued	Indirect Shares	2,385	$1.740	$4,150.000
25 Sep 2026	GRIMWADE, Frederick	Issued	Indirect Shares	14,573	$1.740	$25,357.000

See all changes in directors' interest & trades for XRF Scientific Limited (XRF) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

XRF Management

Name	Position
Andrew Watson	Joint Company Secretary,Chief Financial Officer

XRF Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in XRF Scientific Limited (XRF). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
8,224,200 (6.56%)	D & GD Brown Nom PL
8,115,505 (6.13%)	Michael Karl Korber

XRF Calendar of Events

Date	Event
17 August 2027	Report (Annual)
17 August 2027	Report (Prelim)
17 February 2027	Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us